Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a21eb766df0e1528

Jump to content

Theophylline/ephedra/hydroxyzine

From Wikipedia, the free encyclopedia
(Redirected from Marax)
Theophylline/ephedra/hydroxyzine
Combination of
TheophyllineStimulant
Ephedra (medicine)Stimulant
HydroxyzineAntihistamine
Clinical data
Trade namesMarax
AHFS/Drugs.comMicromedex Detailed Consumer Information
Routes of
administration
By mouth
ATC code
Identifiers
CAS Number
PubChem SID

Theophylline/ephedra/hydroxyzine (trade name Marax) is a drug that was used for the treatment of asthma. It was a combination of theophylline, ephedra,[1] and hydroxyzine, and taken by mouth.[2][3] It is no longer manufactured in the US due to approval of ephedra being withdrawn by the FDA.[citation needed]

See also

[edit]

References

[edit]
  1. Hunt TM (2011). Drug Games: The International Olympic Committee and the Politics of Doping, 1960–2008. University of Texas Press. p. 45. ISBN 978-0-292-73957-4. Retrieved 20 July 2018.
  2. Marax Micromedex Detailed Consumer Information. Accessed 23 April 2021.
  3. Fixley M, Shen DD, Azarnoff DL (June 1977). "Theophylline bioavailability: a comparison of the oral absorption of a theophylline elixir and two combination theophylline tablets to intravenous aminophylline". The American Review of Respiratory Disease. 115 (6): 955–62. doi:10.1164/arrd.1977.115.6.955 (inactive 12 July 2025). PMID 262107.{{cite journal}}: CS1 maint: DOI inactive as of July 2025 (link)